6-Mercaptopurine

Get a Price/Quote

MOQ : 1 Kilograms

6-Mercaptopurine Specification

Usage
Mercaptopurine tablets are not effective prophylaxis or treatment of central nervous system leukemia. Mercaptopurine tablets are not effective in acute myelogenous leukemia, chronic lymphatic leukemia, the lymphomas (including Hodgkins Disease), or solid tumors.

Melting Point
313 dec °C

Molecular Formula
C5H4N4S

Purity
95%

Molecular Weight
152.177 Grams (g)

6-Mercaptopurine Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Kilograms, Per Month

Delivery Time
3-4 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Main Export Market(s)
Western Europe, Middle East, Africa, Central America, South America, Asia, Eastern Europe, North America, Australia

Main Domestic Market
All India

About 6-Mercaptopurine

6-Mercaptopurine analytical standard Synonym: 6-Purinethiol, 6-Thiohypoxanthine CAS Number 50-44-2 Empirical Formula (Hill Notation) C5H4N4S Molecular Weight 152.18 Properties grade analytical standard assay 98.0% (HPLC) shelf life limited shelf life, expiry date on the label storage condition under inert gas impurities 15.0% water

FAQs of 6-Mercaptopurine:

Q: What is the molecular formula of 6-Mercaptopurine?

A: The molecular formula of 6-Mercaptopurine is C5H4N4S.

Q: What is the purity level of 6-Mercaptopurine?

A: The purity level of 6-Mercaptopurine is 95%.

Q: What is the molecular weight of 6-Mercaptopurine?

A: The molecular weight of 6-Mercaptopurine is 152.177 grams (g).

Q: What is the melting point of 6-Mercaptopurine?

A: The melting point of 6-Mercaptopurine is 313 dec C.

Q: Is 6-Mercaptopurine effective for prophylaxis or treatment of central nervous system leukemia?

A: No, Mercaptopurine tablets are not effective for prophylaxis or treatment of central nervous system leukemia.

Q: Can 6-Mercaptopurine be used for treating acute myelogenous leukemia or solid tumors?

A: No, Mercaptopurine tablets are not effective in treating acute myelogenous leukemia, chronic lymphatic leukemia, the lymphomas (including Hodgkins Disease), or solid tumors.

Tell us about your requirement